IPH-3102

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIPH-3102
Drug Alias NameTLR-3 receptor agonist (Innate Pharma)toll-like receptor 3 agonist (Innate Pharma)IPH-31XXIPH-3102
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionToll like receptor 3 agonistsImmunostimulants
TargetsToll like receptor 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnate Pharma SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnate Pharma SA
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A